Nicosia, 23 April 2020 – With a sense of responsibility and constantly responding to the new
needs that the unprecedented health crisis of COVID-19 requires, Novartis Pharma Services
Inc. Cyprus is announcing a donation of $150,000 US dollars to the Cyprus Ministry of
Health’s infrastructure program to address the COVID-19 pandemic, specifically towards the
purchase of ventilators. The initiative aims to support the huge effort being made by the state
and in particular the Ministry of Health.
“Novartis supports the efforts of the Ministry of Health so as to overcome this unprecedented
situation together, “said Mr. Frederik Halberg, General Manager Cyprus & Malta. “This
program will have a significant impact in these difficult times and support will be important and
essential for the people of Cyprus. We remain committed to our mission of expanding access
to healthcare, now more than ever. In this context, we are taking immediate action to
implement this initiative so as to provide support to public hospitals and the relevant
infrastructure fighting the pandemic.”
Utilizing the resources of the COVID-19 Response Fund set up by the parent company,
Novartis Pharma Services Inc. Cyprus, in collaboration with the health ministry’s coordinating
department, supporting the ministry’s infrastructure program which specifically addresses the
COVID-19 pandemic with a donation of 150,000 US dollars towards the purchase of
ventilators.
You can find out more about the COVID-19 Global Response Fund here COVID 19 Global
Response Fund.
About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global
medicines company, we use innovative science and digital technologies to create
transformative treatments in areas of great medical need. In our quest to find new medicines,
we consistently rank among the world’s top companies investing in research and
development. Novartis products reach nearly 800 million people globally and we are finding
innovative ways to expand access to our latest treatments. About 109,000 people of more
than 145 nationalities work at Novartis around the world. Find out more at
https://www.novartis.com.
In Cyprus, Novartis (Pharma Services Inc. Cyprus) operates in the field of prescription
medicines. The headquarters are located in Nicosia and the company employs about 34
people in Cyprus.
For more information:
Novartis Pharma Services Inc.,
73, Makarios Avenue, Methonis Tower
1070 Nicosia
Τel: +357 22 690 690
Fax: +357 22 496 798
Email: novartis.cyprus@novartis.com